Make it Work!:

Harvard Law Review 128, 2014
by I. Glenn Cohen (Faculty Co-Director)

This short essay is part of a Harvard Law Review Symposium honoring Justice Breyer on his 20th Year on The Supreme Court. It examines Breyer's opinions and impact on the…

Read More

Genetic Weapon Against Insects Raises Hope and Fear in Farming

New York Times, January 27, 2014
by Andrew Pollack

Scientists and biotechnology companies are developing what could become the next powerful weapon in the war on pests — one that harnesses a Nobel Prize-winning discovery to kill insects and…

Read More

Genes without Patents

Harvard Gazette, November 14, 2013
by Alvin Powell, featuring I. Glenn Cohen

As Supreme Court Justice Elena Kagan questioned Myriad Genetics’ attorney about patenting genes, Chris Hansen rejoiced. The attorney said that yes, genes should be patentable. But it was only under…

Read More

GMO food fight brings in big bucks in Washington state

Al Jazeera America, October 28, 2013
by Michael Ames

A bitter fight in Washington state over whether to label foods with ingredients that have been genetically modified has attracted tens of millions of dollars in spending, more than $27…

Read More

Chris Hansen on “Dis-Owning Nature: The BRCA Gene Patents and the Supreme Court”

Program on Science, Technology, & Society at HKS, November 12, 2013
by Featuring I. Glenn Cohen as a discussant

ABOUT THE SPEAKER Chris Hansen joined the ACLU in 1973. He spent 10 years at the NYCLU specializing in complex litigation seeking reform of the mental retardation and mental health…

Read More

HLS Panel Discusses Gene Patents

The Harvard Crimson, September 24, 2013
by Andrew Ma

"Panelists at Monday’s discussion about the recent Supreme Court decision against gene patenting agreed that although patenting might provide incentives to aspiring innovators, it often hinders scientific progress, especially when…

Read More

At Harvard Law School, a panel ponders the effects of the Court’s ruling on gene patenting

Spotlight at Harvard Law School, October 3, 2013
by Dick Dahl

Experts in the fields of law, science, and technology gathered at Harvard Law School Sept. 23 for a panel discussion, co-sponsored by the Broad Institute of MIT and HLS' Petrie-Flom…

Read More

Gene Patenting, the Supreme Court’s Myriad Decision, and the Future of Biotechnology:
A Panel Discussion

Monday, September 23, 2013 4:00 PM
Lectures and Panels
Austin 100, Harvard Law School
1515 Massachusetts Ave. , Cambridge, MA
Watch Event Recordings

Moderated by Dean Martha Minow of Harvard Law School, this panel will focus on the impact of the Supreme Court's recent…

Read More

Association for Molecular Pathology v. Myriad Genetics

by Oyez Project

In June 2013, the Supreme Court held that naturally occurring gene sequences and their naturally occurring derivatives are not patent eligible.  This link includes a brief summary of the case,…

Read More

Myriad Gene Patent Litigation

Genomics Law Report

This link provides several viewpoints regarding the Myriad Genetics case.

Read More

7 Takeaways from Supreme Court’s Gene Patent Decision

Daily News, National Geographic

Shortly after the Supreme Court ruling in Myriad, this article summarizes the implications of the decision and its influence on the biotech industry.

Read More

Gene Patents

The Hastings Center Bioethics Briefing Book
by Robert Cook-Deegan

Intended for a lay audience, this chapter outlines key issues in the debate about gene patents and summarizes historical developments in the field.

Read More

Patents in Genomics and Human Genetics

Annual Review of Genomics and Human Genetics
by Robert Cook-Deegan and Christopher Heaney

This article provides a more detailed and scholarly overview of the issues.

Read More

Debunking the Myth that Whole-Genome Sequencing Infringes Thousands of Gene Patents

Nature Biotechnology
by Christopher M. Holman

This article addresses misconceptions regarding gene patents and whole-genome sequencing.

Read More

Mayo Collaborative Services v. Prometheus Laboratories

by Oyez Project

In this case, the Supreme Court held that the processes involved in a test for proper dosages of drug treatments are unpatentable laws of nature.

Read More

Personalized Medicine Patenting

Wednesday, March 06, 2013
Lectures and Panels
Austin Hall 111, Harvard Law School
Watch Event Recordings

Pharmaceutical researchers pursue medical treatment and diagnostic methods to target diseases specific to certain demographic groups. Such pursuit is often motivated…

Read More

Mayo v. Prometheus: Implications for Patents, Biotechnology, and Personalized Medicine

by Congressional Research Service

This article discusses the implications of the Mayo v. Prometheus decision, including its potential impact on gene patents.  It also suggests possible routes that Congress can take on the issue…

Read More

Health Law Year in P/Review

Friday, February 01, 2013
Lectures and Panels
Wasserstein Hall 2036, Milstein East C, Harvard Law School
Watch Event Recordings

2012 was an historic year for health law, with the Supreme Court issuing the final word on the constitutionality of…

Read More

Cohen amicus brief discussed before Supreme Court

Supreme Court Transcript, April 15, 2013


Read More